Skyhawk Therapeutics Completes New Investment Round cataniaoggi.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cataniaoggi.it Daily Mail and Mail on Sunday newspapers.
Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development
News provided by
Share this article
Share this article
Elliot Ehrich MD brings 25+ years R&D and clinical development leadership experience to the company; Graeme Smith PhD DABT brings 15+ years of nonclinical drug development leadership experience to the company.
WALTHAM, Mass., April 13, 2021 /PRNewswire/ Skyhawk Therapeutics today announced the appointments of Dr. Elliot Ehrich as its President, and Dr. Graeme Smith as its Senior Vice President of Nonclinical Development. Skyhawk builds novel small molecule RNA modifying drug candidates for deployment across a wide range of oncology, neurology and autoimmune diseases.